Category: AIM (Aging In Motion)

April 20, 2017

Update on Patient-Focused Drug Development Meeting on Sarcopenia

On April 6, the U.S. Food and Drug Administration held a public meeting on Patient-Focused Drug Development (PFDD) for sarcopenia. The focus of the meeting was to obtain patient perspectives on “symptoms and the daily impacts of their condition, current approaches to treatment, and decision factors taken into account when selecting a treatment.”
March 27, 2017

Join FDA’s PFDD Meeting on Sarcopenia, April 6

The U.S. Food and Drug Administration is seeking people with sarcopenia to share their comments at a public meeting on Patient-Focused Drug Development (PFDD) for Sarcopenia on April 6, from 1 p.m. to 5 p.m. EST.   
February 2, 2017

Patient Perspectives on Sarcopenia Sought by the FDA

If you or a loved one has sarcopenia or if you want to understand more about how sarcopenia could impact you, the U.S. Food and Drug Administration wants to hear from you.
January 26, 2017

AIM Coalition’s Webinar on ICD-10 for Sarcopenia Now Available

The Aging in Motion (AIM) Coalition recently hosted a webinar about the ICD-10 code for sarcopenia, titled "An ICD-10 Code for Sarcopenia: Implications for Diagnosis and Clinical Practice." An archived video of the webinar is now available. 
January 12, 2017

Webinar on an ICD-10 Code for Sarcopenia/January 24

In 2016, the Aging in Motion Coalition’s (AIM) proposal to establish an ICD-10-CM code for sarcopenia was accepted by the Centers for the Disease Control and Prevention. To provide additional insight into the process and its importance, AIM will be hosting a one-hour webinar on January 24, 2017.
December 15, 2016

AIM Coalition Held Second Annual Meeting

On December 2, the Aging in Motion (AIM) Coalition hosted its second annual meeting in Bethesda, Md., to discuss developments and advances in clinical research and treatment of sarcopenia.
December 2, 2016

AIM Coalition Meeting Spotlights Sarcopenia Research Advances

The Aging in Motion (AIM) Coalition hosted its second annual meeting with U.S. Food and Drug Administration (FDA) leaders and leading scientists, industry representatives, and advocates to discuss developments and advances in clinical research and treatment of sarcopenia in Bethesda, Md.
December 1, 2016

2016 Annual Aging in Motion (AIM) Coalition Meeting

The Aging in Motion (AIM) Coalition will hold its annual meeting on Thursday, December 1, 2016 at the Bethesda North Marriott Hotel & Conference Center. 
August 23, 2016

Alliance Comments on PDUFA VI Commitment Letter

The Alliance provided comments in response to the U.S. Food and Drug Administration's PDUFA VI Commitment Letter.
July 13, 2016

AIM Coalition Featured in MedPageToday

The Aging in Motion Coalition was featured in MedPageToday’s online resource article, “Sarcopenia: Muscle Weakness Creeps Up With Age.”